Respiratory Care Devices Market By Product (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables and Accessories) , By End User (Hospitals, Home Care) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The respiratory care devices market was valued at $22.9 billion in 2023, and is projected t%li%reach $47.9 billion by 2033, growing at a CAGR of 7.6% from 2024 t%li%2033.
Respiratory care device is a medical device that supports breathing by delivering controlled amounts of oxygen t%li%patients wh%li%cannot breathe adequately on their own. These devices are crucial in the treatment and management of various respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and respiratory infections. They play a vital role in both acute and chronic respiratory care and improving patients' quality of life.
The growth of the global respiratory care devices market is majorly driven by alarming rise in prevalence of respiratory diseases and need for cutting-edge respiratory care devices. Increase in air pollution, sedentary lifestyles, smoking & tobacc%li%use, and lack of physical activity have led t%li%increase in cases of respiratory diseases. According t%li%a study published by the World Health Organization in March 2023, chronic obstructive pulmonary disease (COPD) was registered t%li%be the third leading cause of death worldwide in 2019, causing 3.23 million deaths. Tobacc%li%smoking accounts for over 70% of COPD cases in high-income countries. Moreover, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed t%li%the fact that aging is associated with multiple structural changes in the respiratory system, resulting in increased susceptibility t%li%respiratory diseases. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated t%li%increase t%li%1.4 billion by 2030 and 2.1 billion by 2050. With increasing aged population, the incidence of respiratory conditions is expected t%li%rise significantly. Furthermore, increase in trend toward home-based respiratory care allows patients t%li%manage chronic conditions comfortably at home, reducing the need for hospital visits. Integration of smart technology in respiratory care devices, such as Bluetooth connectivity, remote monitoring, and data analytics, further allows for better management and tracking of respiratory health. However, high cost associated with these devices hampers the market growth. Acquiring and deploying
these devices further incur additional expenses, which deter the growth of the market. Moreover, lack of appropriate health facilities t%li%meet population needs in most countries and limited access restrain the market growth. On the contrary, increase in government initiatives t%li%provide access t%li%cutting-edge respiratory care services is expected t%li%offer remunerative opportunities for the expansion of the market during the forecast period. In addition, manufacturers are integrating diagnostic features such as built-in pulse oximetry and spirometry in respiratory care devices that will enable comprehensive respiratory monitoring, which is expected t%li%open new avenues for the growth of the market during the forecast period.
The global respiratory care devices market is segmented int%li%product, end user, and region. On the basis of product, the market is fragmented int%li%therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. Depending on end user, it is segregated int%li%hospitals and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competition Analysis
Competitive analysis and profiles of the major players in the global respiratory care devices market include Masimo, Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V., Drдgerwerk AG & Co. KGaA, Becton, Dickinson and Company, Medtronic, ResMed, Hamilton Medical, Chart Industries, and Invacare Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
By Product
? Bilevel PAP (BPAP) devices
? Automatic positive airway pressure (APAP) devices
? Full-face masks
? Nasal pillow masks
? Oral masks
? Infant/neonatal ventilator
? Portable oxygen concentrators
? Wrist-worn pulse oximeters
? Hand-held pulse oximeters
? Fingertip pulse oximeters
? Table-top/bedside pulse oximeters
Respiratory care device is a medical device that supports breathing by delivering controlled amounts of oxygen t%li%patients wh%li%cannot breathe adequately on their own. These devices are crucial in the treatment and management of various respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and respiratory infections. They play a vital role in both acute and chronic respiratory care and improving patients' quality of life.
The growth of the global respiratory care devices market is majorly driven by alarming rise in prevalence of respiratory diseases and need for cutting-edge respiratory care devices. Increase in air pollution, sedentary lifestyles, smoking & tobacc%li%use, and lack of physical activity have led t%li%increase in cases of respiratory diseases. According t%li%a study published by the World Health Organization in March 2023, chronic obstructive pulmonary disease (COPD) was registered t%li%be the third leading cause of death worldwide in 2019, causing 3.23 million deaths. Tobacc%li%smoking accounts for over 70% of COPD cases in high-income countries. Moreover, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed t%li%the fact that aging is associated with multiple structural changes in the respiratory system, resulting in increased susceptibility t%li%respiratory diseases. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated t%li%increase t%li%1.4 billion by 2030 and 2.1 billion by 2050. With increasing aged population, the incidence of respiratory conditions is expected t%li%rise significantly. Furthermore, increase in trend toward home-based respiratory care allows patients t%li%manage chronic conditions comfortably at home, reducing the need for hospital visits. Integration of smart technology in respiratory care devices, such as Bluetooth connectivity, remote monitoring, and data analytics, further allows for better management and tracking of respiratory health. However, high cost associated with these devices hampers the market growth. Acquiring and deploying
these devices further incur additional expenses, which deter the growth of the market. Moreover, lack of appropriate health facilities t%li%meet population needs in most countries and limited access restrain the market growth. On the contrary, increase in government initiatives t%li%provide access t%li%cutting-edge respiratory care services is expected t%li%offer remunerative opportunities for the expansion of the market during the forecast period. In addition, manufacturers are integrating diagnostic features such as built-in pulse oximetry and spirometry in respiratory care devices that will enable comprehensive respiratory monitoring, which is expected t%li%open new avenues for the growth of the market during the forecast period.
The global respiratory care devices market is segmented int%li%product, end user, and region. On the basis of product, the market is fragmented int%li%therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. Depending on end user, it is segregated int%li%hospitals and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competition Analysis
Competitive analysis and profiles of the major players in the global respiratory care devices market include Masimo, Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V., Drдgerwerk AG & Co. KGaA, Becton, Dickinson and Company, Medtronic, ResMed, Hamilton Medical, Chart Industries, and Invacare Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
By Product
- Therapeutic Devices
- Positive airway pressure (PAP) devices
? Bilevel PAP (BPAP) devices
? Automatic positive airway pressure (APAP) devices
- Mask
? Full-face masks
? Nasal pillow masks
? Oral masks
- Ventilators
? Infant/neonatal ventilator
- Nebulizers
- Humidifiers
- Oxygen concentrators
? Portable oxygen concentrators
- Inhalers
- Reusable Resuscitators
- Nitric oxide delivery units
- Capnographs
- Gas analyzers
- Oxygen hoods
- Monitoring Devices
- Pulse oximeters
? Wrist-worn pulse oximeters
? Hand-held pulse oximeters
? Fingertip pulse oximeters
? Table-top/bedside pulse oximeters
- Diagnostic Devices
- Spirometers
- Polysomnography (PSG) devices
- Peak flow meters
- Consumables and Accessories
- Disposable masks
- Disposable resuscitators
- Tracheostomy tubes
- Nasal cannulas
- Others
- Hospitals
- Home Care
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Masimo
- Fisher & Paykel Healthcare Limited.
- Koninklijke Philips N.V.
- Drдgerwerk AG & Co. KGaA
- Becton, Dickinson and Company
- Medtronic
- ResMed
- Hamilton Medical
- Chart Industries
- Invacare Corporation
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: SPINE BIOLOGICS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Spinal Allografts
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Bone Graft Substitutes
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Cell-Based Matrix
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: SPINE BIOLOGICS MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Outpatient Facilities
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: SPINE BIOLOGICS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Spine Biologics Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Spine Biologics Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Spine Biologics Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Spine Biologics Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Spine Biologics Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Spine Biologics Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Spine Biologics Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Spine Biologics Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Spine Biologics Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Spine Biologics Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Spine Biologics Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End User
6.4.7. Australia Spine Biologics Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End User
6.4.8. India Spine Biologics Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Spine Biologics Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Spine Biologics Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Spine Biologics Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Spine Biologics Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Spine Biologics Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Spine Biologics Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Stryker Corporation
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. NuVasive, Inc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Orthofix
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Johnson And Johnson
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Exactech, Inc
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Zimmer Biomet Holding, Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Arthrex, Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Medtronic Plc
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Organogenesis Inc
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Kuros Biosciences
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: SPINE BIOLOGICS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Spinal Allografts
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Bone Graft Substitutes
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Cell-Based Matrix
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: SPINE BIOLOGICS MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Outpatient Facilities
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: SPINE BIOLOGICS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Spine Biologics Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Spine Biologics Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Spine Biologics Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Spine Biologics Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Spine Biologics Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Spine Biologics Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Spine Biologics Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Spine Biologics Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Spine Biologics Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Spine Biologics Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Spine Biologics Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End User
6.4.7. Australia Spine Biologics Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End User
6.4.8. India Spine Biologics Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Spine Biologics Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Spine Biologics Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Spine Biologics Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Spine Biologics Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Spine Biologics Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Spine Biologics Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Stryker Corporation
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. NuVasive, Inc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Orthofix
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Johnson And Johnson
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Exactech, Inc
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Zimmer Biomet Holding, Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Arthrex, Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Medtronic Plc
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Organogenesis Inc
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Kuros Biosciences
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
